These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29437466)

  • 21. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils.
    Stănescu D; Sanna A; Veriter C; Kostianev S; Calcagni PG; Fabbri LM; Maestrelli P
    Thorax; 1996 Mar; 51(3):267-71. PubMed ID: 8779129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary nutrients associated with preservation of lung function in Hispanic and non-Hispanic white smokers from New Mexico.
    Leng S; Picchi MA; Tesfaigzi Y; Wu G; Gauderman WJ; Xu F; Gilliland FD; Belinsky SA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3171-3181. PubMed ID: 29133979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
    Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
    Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting lung cancer by detecting aberrant promoter methylation in sputum.
    Palmisano WA; Divine KK; Saccomanno G; Gilliland FD; Baylin SB; Herman JG; Belinsky SA
    Cancer Res; 2000 Nov; 60(21):5954-8. PubMed ID: 11085511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
    Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
    Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers.
    Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L
    Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH; Kim JS; Ji YI; Shim YM; Kim H; Han J; Park J
    Cancer Res; 2003 Jul; 63(13):3743-6. PubMed ID: 12839968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual and joint contributions of genetic and methylation risk scores for enhancing lung cancer risk stratification: data from a population-based cohort in Germany.
    Yu H; Raut JR; Schöttker B; Holleczek B; Zhang Y; Brenner H
    Clin Epigenetics; 2020 Jun; 12(1):89. PubMed ID: 32552915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Association of lung function decline with the microsatellite polymorphism in the heme oxygenase-1 gene promoter, in a general population sample. Results from the Longitudinal European Community Respiratory Health Survey (ECRHS-France)].
    Aubier M; Guenegou A; Benessiano J; Leynaert B; Boczkowski J; Neukirch F
    Bull Acad Natl Med; 2006; 190(4-5):877-90; discussion 890-1. PubMed ID: 17195613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
    Leng S; Do K; Yingling CM; Picchi MA; Wolf HJ; Kennedy TC; Feser WJ; Baron AE; Franklin WA; Brock MV; Herman JG; Baylin SB; Byers T; Stidley CA; Belinsky SA
    Clin Cancer Res; 2012 Jun; 18(12):3387-95. PubMed ID: 22510351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers.
    Zöchbauer-Müller S; Lam S; Toyooka S; Virmani AK; Toyooka KO; Seidl S; Minna JD; Gazdar AF
    Int J Cancer; 2003 Nov; 107(4):612-6. PubMed ID: 14520700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA methylation is associated with lung function in never smokers.
    de Vries M; Nedeljkovic I; van der Plaat DA; Zhernakova A; Lahousse L; Brusselle GG; ; Amin N; van Duijn CM; Vonk JM; Boezen HM
    Respir Res; 2019 Dec; 20(1):268. PubMed ID: 31791327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas.
    Leng S; Bernauer AM; Hong C; Do KC; Yingling CM; Flores KG; Tessema M; Tellez CS; Willink RP; Burki EA; Picchi MA; Stidley CA; Prados MD; Costello JF; Gilliland FD; Crowell RE; Belinsky SA
    Clin Cancer Res; 2011 Apr; 17(7):2014-23. PubMed ID: 21355081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA
    Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.
    Tessema M; Tassew DD; Yingling CM; Do K; Picchi MA; Wu G; Petersen H; Randell S; Lin Y; Belinsky SA; Tesfaigzi Y
    Lung Cancer; 2020 Aug; 146():189-196. PubMed ID: 32559455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers.
    Tessema M; Yu YY; Stidley CA; Machida EO; Schuebel KE; Baylin SB; Belinsky SA
    Carcinogenesis; 2009 Jul; 30(7):1132-8. PubMed ID: 19435948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.
    Tessema M; Rossi MR; Picchi MA; Yingling CM; Lin Y; Ramalingam SS; Belinsky SA
    Lung Cancer; 2018 Sep; 123():99-106. PubMed ID: 30089603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
    Belinsky SA; Liechty KC; Gentry FD; Wolf HJ; Rogers J; Vu K; Haney J; Kennedy TC; Hirsch FR; Miller Y; Franklin WA; Herman JG; Baylin SB; Bunn PA; Byers T
    Cancer Res; 2006 Mar; 66(6):3338-44. PubMed ID: 16540689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking.
    Georgiou E; Valeri R; Tzimagiorgis G; Anzel J; Krikelis D; Tsilikas C; Sarikos G; Destouni C; Dimitriadou A; Kouidou S
    Eur J Cancer Prev; 2007 Oct; 16(5):396-402. PubMed ID: 17923809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction.
    Maestrelli P; Calcagni PG; Saetta M; Bertin T; Mapp CE; Sanna A; Veriter C; Fabbri LM; Stanescu D
    Am J Respir Crit Care Med; 1996 Nov; 154(5):1296-300. PubMed ID: 8912739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.